CN104661668A - 从山蚂蝗属制备植物提取物的方法及其提取物 - Google Patents

从山蚂蝗属制备植物提取物的方法及其提取物 Download PDF

Info

Publication number
CN104661668A
CN104661668A CN201380022605.4A CN201380022605A CN104661668A CN 104661668 A CN104661668 A CN 104661668A CN 201380022605 A CN201380022605 A CN 201380022605A CN 104661668 A CN104661668 A CN 104661668A
Authority
CN
China
Prior art keywords
pinitol
extract
plant
fruit thinning
aforementioned
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380022605.4A
Other languages
English (en)
Chinese (zh)
Inventor
F·梅斯
L·彼得斯
A·弗利特克
S·阿佩尔
N·赫尔曼斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mark Lewis-Francis Metz Co
Original Assignee
Mark Lewis-Francis Metz Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mark Lewis-Francis Metz Co filed Critical Mark Lewis-Francis Metz Co
Publication of CN104661668A publication Critical patent/CN104661668A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
CN201380022605.4A 2012-03-20 2013-03-20 从山蚂蝗属制备植物提取物的方法及其提取物 Pending CN104661668A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE2012/0195 2012-03-20
BE201200195A BE1020835A5 (nl) 2012-03-20 2012-03-20 Werkwijze voor het vervaardigen van een plantenextract, i.h.b. uit desmodium.
PCT/BE2013/000014 WO2013166563A1 (en) 2012-03-20 2013-03-20 Method for producing a plant extract from desmodium and extract thereof

Publications (1)

Publication Number Publication Date
CN104661668A true CN104661668A (zh) 2015-05-27

Family

ID=48463649

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380022605.4A Pending CN104661668A (zh) 2012-03-20 2013-03-20 从山蚂蝗属制备植物提取物的方法及其提取物

Country Status (8)

Country Link
US (1) US20150050368A1 (enExample)
EP (1) EP2849769B1 (enExample)
JP (1) JP2015515457A (enExample)
CN (1) CN104661668A (enExample)
BE (1) BE1020835A5 (enExample)
CA (1) CA2868128A1 (enExample)
IN (1) IN2014DN08769A (enExample)
WO (1) WO2013166563A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105092759A (zh) * 2015-08-11 2015-11-25 苏州优谱德精密仪器科技有限公司 用于石油化工的气质联用分析设备
CN107753495A (zh) * 2017-10-18 2018-03-06 朗致集团万荣药业有限公司 一种含有红杉醇的药物组合物及其制备方法与用途
CN109952109A (zh) * 2016-11-02 2019-06-28 阿尔法诺索斯简易两合公司 作为抗微生物剂和/或抗生物膜剂的草药组合物的提取物
CN116953105A (zh) * 2023-07-13 2023-10-27 梧州市中医医院 一种蛇药酒hplc指纹图谱的构建方法及其成分含量测定方法
CN117169402A (zh) * 2023-08-17 2023-12-05 梧州市中医医院 一种小叶三点金hplc指纹图谱的构建方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014348232A1 (en) * 2013-11-18 2016-06-30 Del Mar Pharmaceuticals HPLC analysis of impurities in dianhydrogalactitol
FR3085269B1 (fr) * 2018-08-31 2021-10-01 Normaphar Composition pour utilisation dans le traitement preventif et / ou curatif de la steatose hepatique non alcoolique
BE1026580B1 (fr) * 2018-08-31 2020-03-31 Normaphar Composition pour utilisation dans le traitement préventif et/ou curatif de la stéatose hépatique non alcoolique
US20200069758A1 (en) * 2018-08-31 2020-03-05 Normaphar Sa Composition for use in the preventive and/or curative treatment of non-alcoholic fatty liver disease
IT201900016520A1 (it) * 2019-09-17 2021-03-17 Phytoitalia Srl Preparato erbale per il trattamento della steatosi epatica
FR3125706B1 (fr) * 2021-07-29 2024-05-03 Urgo Rech Innovation Et Developpement Produit de combinaison pour stimuler le fonctionnement des cellules hépatiques et faciliter l’endormissement
CN116724887B (zh) * 2023-08-15 2023-10-24 成都第一制药有限公司 一种山莨菪多倍体的高效诱导方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0309342A1 (fr) * 1987-09-24 1989-03-29 Pierre Tubery Utilisation du desmodium pour le traitement des hépatites et médicament correspondant
WO2004084875A1 (en) * 2003-03-26 2004-10-07 Amicogen Inc. Use of pinitol or chiroinositol for protecting the liver
CN101492350A (zh) * 2009-03-05 2009-07-29 上海交通大学 从植物刺槐中制备d-松醇的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5132139B2 (ja) * 2006-11-30 2013-01-30 株式会社ノエビア 皮膚外用剤及び飲食品

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0309342A1 (fr) * 1987-09-24 1989-03-29 Pierre Tubery Utilisation du desmodium pour le traitement des hépatites et médicament correspondant
WO2004084875A1 (en) * 2003-03-26 2004-10-07 Amicogen Inc. Use of pinitol or chiroinositol for protecting the liver
CN101492350A (zh) * 2009-03-05 2009-07-29 上海交通大学 从植物刺槐中制备d-松醇的方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《AUST. J. CHEM》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105092759A (zh) * 2015-08-11 2015-11-25 苏州优谱德精密仪器科技有限公司 用于石油化工的气质联用分析设备
CN109952109A (zh) * 2016-11-02 2019-06-28 阿尔法诺索斯简易两合公司 作为抗微生物剂和/或抗生物膜剂的草药组合物的提取物
CN107753495A (zh) * 2017-10-18 2018-03-06 朗致集团万荣药业有限公司 一种含有红杉醇的药物组合物及其制备方法与用途
CN116953105A (zh) * 2023-07-13 2023-10-27 梧州市中医医院 一种蛇药酒hplc指纹图谱的构建方法及其成分含量测定方法
CN116953105B (zh) * 2023-07-13 2025-10-10 梧州市中医医院 一种蛇药酒hplc指纹图谱的构建方法及其成分含量测定方法
CN117169402A (zh) * 2023-08-17 2023-12-05 梧州市中医医院 一种小叶三点金hplc指纹图谱的构建方法
CN117169402B (zh) * 2023-08-17 2025-11-28 梧州市中医医院 一种小叶三点金hplc指纹图谱的构建方法

Also Published As

Publication number Publication date
IN2014DN08769A (enExample) 2015-05-22
WO2013166563A9 (en) 2014-03-06
US20150050368A1 (en) 2015-02-19
WO2013166563A1 (en) 2013-11-14
EP2849769B1 (en) 2020-07-01
BE1020835A5 (nl) 2014-06-03
JP2015515457A (ja) 2015-05-28
CA2868128A1 (en) 2013-11-14
EP2849769A1 (en) 2015-03-25

Similar Documents

Publication Publication Date Title
EP2849769B1 (en) Method for producing a plant extract from desmodium and its extract
Alcázar Magaña et al. Caffeoylquinic acids: Chemistry, biosynthesis, occurrence, analytical challenges, and bioactivity
López-Cobo et al. Determination of phenolic compounds and antioxidant activity of a Mediterranean plant: The case of Satureja montana subsp. kitaibelii
He et al. A sensitive LC–MS/MS method for simultaneous determination of six flavonoids in rat plasma: Application to a pharmacokinetic study of total flavonoids from mulberry leaves
Tao et al. Comparison of three officinal Chinese pharmacopoeia species of Glycyrrhiza based on separation and quantification of triterpene saponins and chemometrics analysis
Boudjelal et al. Antidiabetic effects of aqueous infusions of Artemisia herba-alba and Ajuga iva in alloxan-induced diabetic rats
Zainol et al. Profiling of Centella asiatica (L.) Urban extract
Achour et al. A comprehensive characterisation of rosemary tea obtained from Rosmarinus officinalis L. collected in a sub‐humid area of Tunisia
Lee et al. Determination of flavonoids from Cirsium japonicum var. maackii and their inhibitory activities against aldose reductase
US20120135094A1 (en) Oregano and mint anti-inflammatory compositions and methods
Cassani et al. Antidepressant-like and toxicological effects of a standardized aqueous extract of Chrysactinia mexicana A. Gray (Asteraceae) in mice
Li et al. Chemical and bioactive comparison of flowers of Panax ginseng Meyer, Panax quinquefolius L., and Panax notoginseng Burk.
Desta et al. Antioxidant activities and liquid chromatography with electrospray ionization tandem mass spectrometry characterization and quantification of the polyphenolic contents of Rumex nervosus Vahl leaves and stems
Kumar Phytochemical, pharmacological activities and ayurvedic significances of magical plant Mimosa pudica Linn
Misra et al. Hyphenated high-performance thin-layer chromatography for profiling of some Indian natural efficiency enhancers
Romo-Pérez et al. Chronic hypoglycemic effect and phytochemical composition of Smilax moranensis roots
Elattar et al. Insights into bioactive constituents of onion (Allium cepa L.) waste: a comparative metabolomics study enhanced by chemometric tools
Garg et al. RP-HPLC method development and validation for simultaneous estimation of rutin and quercetin in Morus alba L. leaf extract
Ajdert et al. Liquid chromatographic method for the quantification of salidroside and cinnamyl alcohol glycosides for quality control of golden root (Rhodiola rosea L.)
Denes et al. Polyphenol content of Ononis arvensis L. and Rhinanthus serotinus (Schönh. ex Halácsy & Heinr. Braun) Oborny used in the Transylvanian ethnomedicine
Gan et al. Simultaneous determination and pharmacokinetic study of four phenol compounds in rat plasma by ultra‐high performance liquid chromatography with tandem mass spectrometry after oral administration of Echinacea purpurea extract
Bae et al. Development and validation of a UHPLC-PDA-MS method for the quantitative analysis of anthraquinones in Bulbine natalensis extracts and dietary supplements
Oliveira et al. Bioactive natural products from Piper betle L. Leaves and their α-glucosidase inhibitory potential
Baonda et al. Evaluation of antidiabetic activity of the ethanol extract of Momordica charantia L. and the identification of charantine by gas chromatography coupled with Mass spectrometry
Zhao et al. Comprehensive pharmacokinetic profiling of twelve compounds from Phellinus Igniarius extract in rats by UHPLC-MS/MS

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150527